A51
1 known investors
A51 develops a technology platform for programming RNA molecules to control cell behavior. The company operates in the biotech/synthetic biology sector.
1 known investors
A51 develops a technology platform for programming RNA molecules to control cell behavior. The company operates in the biotech/synthetic biology sector.